Medical Device Market Access

Medtech commercialisation: your expert-led journey to global markets

We are on a mission to ensure that medical technologies are available to the patients who need them, whilst meeting the needs of the healthcare environment.

We work in expert-led partnerships with innovators across the healthcare sector, providing commercialisation strategy, evidence synthesis and analysis, and value demonstration services, supporting the journey from R&D to market.

If you find yourself asking any of these questions, we can help:

  • We have our CE mark, what should we do next?
  • How do we get funding?
  • How does my product align with national policy objectives?
  • What is the right approach for optimal access and reimbursement?
  • What evidence do we need to show that our product is both viable and brilliant?
  • Who do I need to talk to in health systems? What are their challenges and what are they looking for?
  • How can we clearly and consistently communicate the unmet need our innovation resolves?
  • How can we defend against competitors?
  • What is an appropriate pricing strategy?
  • What do local reimbursement considerations mean for my product and pricing strategy?
  • How do we sell our innovation to healthcare systems?

Market access for Medtech

Bringing a Medtech innovation to market, be it a device, diagnostic or digital solution, offers both opportunities and challenges. Above all, it is essential to demonstrate that the technology provides clinical and economic value and has a place in treatment pathways alongside, or in preference to, other products.

The route to market for Medtech varies between healthcare systems and product types, and it is crucial to understand the considerations for access and the market landscape relevant to your product.

In England, for example, a technology may be submitted for consideration in NICE’s Medical Technologies Evaluation Programme (MTEP) and potentially routed to medical technologies guidance, diagnostics guidance, or Medtech innovation briefings.

To discuss the opportunities for your innovation with our experts, get in touch using the form below.

    Keep me up to date with the latest news and events.

    Bringing your healthcare innovation to market

    As your global commercialisation partner, we offer support throughout the product lifecycle, across all evidence and access hurdles. Our experts can support with:

    • Education and training to support HEOR and market access

      Education and training to support HEOR and market access

    • Demonstration of economic value

      Demonstration of economic value

    • Generation of a robust evidence base

      Generation of a robust evidence base

    • Optimisation of global commercialisation stratgey and tactics

      Optimisation of global commercialisation stratgey and tactics

    • Development of a compelling value proposition and narrative

      Development of a compelling value proposition and narrative

    • Deep understanding of local landscapes and stakeholders

      Deep understanding of local landscapes and stakeholders

    • Successful national reimbursement

      Successful national reimbursement

    Medtech market access and commercialisation support

    Our in-house experts are here to help with the your commercialisation strategy and product launch. We can:

    • Map out your route to market by researching the market landscape, and develop a bespoke launch strategy
    • Understand the evidence requirements of key healthcare decision makers and identify gaps in the evidence package for your product, relevant to HTA and healthcare provider evidence requirements
    • Demonstrate the economic value of your product by building robust economic models that align with HTA requirements and the latest technical methodologies
    • Synthesise the evidence you need to support your value proposition, with literature reviews (targeted or systematic) and statistical analyses
    • Help you describe your product and its benefits with a clear, compelling value proposition that reflects the needs of payers, HTA agencies and other key decision makers
    • Validate the principles and assumptions of your strategy and value proposition with our global network of payers, clinicians and other affiliates, including over 100 contracted Associates working in the NHS
    • Develop impactful dossiers for submission to the NICE Medical Technologies Evaluation Programme (MTEP) or Diagnostics Assessment Programme (DAP)
    • Provide all the tools you need to take your innovation to healthcare leaders across the NHS and beyond with an impactful customer communication strategy

    Digital conversation aids for Medical Device market access

    Conversations with healthcare decision-makers are greatly enhanced with interactive digital visual aids and cost calculators that effectively communicate the clinical and economic value of your technology to their local environment.

    Our fully in-house creative teams, which include value consultants, health economists, designers, and developers, collaborate with you to produce robust and visually engaging communication tools that can be programmed to work across all digital devices.

    Click the button below to view our demo medical device communication tool.

    View Demo
    Medtech Budget Impact Model - Demo - Diabetic Foot

    Why choose Mtech Access to bring your medical device to market?

    • We bring extensive experience from our work with top Medical Device companies, supporting their market access and customer engagement strategy
    • We understand the nuances of Medtech market access, but can also utilise our in depth experience with Pharmaceutical and other life sciences clients
    • Our in-house developers and designers collaborate directly with our value communication experts, health economists, and medical writers to create your materials – delivering a seamless experience
    • We ensure the principles and assumptions behind our approach align with the needs of your customers by consulting with a broad network of payers, clinicians, and other stakeholders across global markets
    • In the UK we have close relationships with over 100 contracted Associates working in the NHS, who work directly with us on projects to help ensure our market access strategies and messages will resonate with NHS decision-makers
    • We combine evidence and creativity to deliver resources that work for your account managers
    • We are a full-service Veeva partner, able to leverage Veeva’s full functionality to deliver the best possible experience for your teams and customers

    Featured Case Studies

    • Communicating value to healthcare customers in key markets: A global value story and US-market specific brochures

      View Case Study
    • Exploring the US market landscape

      Exploring the US market landscape and developing strategy for a digital health technology

      View Case Study
    • Communicating value with a suite of visually impactful materials connected via a digital platform

      Communicating value with a suite of visually impactful materials connected via a digital platform

      View Case Study
    • Challenging European policy proposals with an evidence-driven submission on behalf of a cross-industry consortium

      Challenging European policy proposals with an evidence-driven submission on behalf of a cross-industry consortium

      View Case Study

    • Exploring funding and reimbursement routes for digital health technologies across EU4, UK and US

      View Case Study

    • Understanding the diagnostic market access landscape in the UK

      View Case Study
    “

    “The team at Mtech Access were very switched on and collaborative, and delivered a budget impact model with the versatility and robustness that we were looking for.”

    Director of Commercial & Access StrategyDiagnostics Company
    “

    “The UK Diagnostic Landscape Study has proved to be really good value for money – we’re really pleased. The report has provided our UK team with a lot more detail than we had before, and we are taking learnings forward to apply to our European strategy.”

    Market Access and HEOR DirectorDiagnostics and Medical Device company
    “

    “We have definitely seen benefits from the NHS update sessions. The insights gained have helped us build value propositions which are well received and accepted.”

    Commercial DirectorTop 20 Medical Devices company
    “

    “The proposal, cost and timelines were all great and I was pleased with the project management. I previously worked at several agencies, so I always think about how much I would have charged for similar services, and your costs were spot on.”

    Communication SpecialistMedical Device Company
    “

    “Mtech Access is the best consultancy, in my opinion, due to the calibre of the people. The team were really easy to work with, were quick to action everything, and kept us updated on the whole process”

    Senior Market Access and Reimbursement ManagerMedtech Company
    “

    "We were and are very happy with the work done by the Mtech Access team on this project. Overall, we have a reliable, organized and dedicated partner who is able to quickly implement changes and feedback. All of this while having a very positive work atmosphere that makes one want to work on the project."

    Global Market Access and Health Economics ManagerMedtech Company

    Why choose Mtech Access to support your Medtech Market Access strategy?

    • We bring extensive experience from our work with top Medical Device companies, supporting their market access and customer engagement strategy
    • We understand the nuances of Medtech market access, but can also utilise our in depth experience with Pharmaceutical and other life sciences clients
    • Our in-house developers and designers collaborate directly with our value communication experts, health economists, and medical writers to create your materials – delivering a seamless experience
    • We ensure the principles and assumptions behind our approach align with the needs of your customers by consulting with a broad network of payers, clinicians, and other stakeholders across global markets
    • In the UK we have close relationships with over 100 contracted Associates working in the NHS, who work directly with us on projects to help ensure our market access strategies and messages will resonate with NHS decision-makers
    • We combine evidence and creativity to deliver resources that work for your account managers
    • We are a full-service Veeva partner, able to leverage Veeva’s full functionality to deliver the best possible experience for your teams and customers

    Articles related to Medtech and Medical Device Market Access

    US and European market access for medical devices – free guide

    US and European Market Access for Medical Devices – Free Guide

    We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available…

    Evidence strategy for Medical Technologies and Diagnostics

    Evidence strategy for Medical Technologies and Diagnostics

    Join us for this live webinar on Friday 12th January at 2.00pm (GMT)/3.00pm (CET)/9.00am (EST) where our experts will be exploring evidence strategies for medical devices, diagnostics and digital health.

    Market access routes for medical devices: The Innovative Devices Access Pathway (IDAP)

    What is IDAP? As the IDAP pilot opens, we explore how this new pathway offers a fast-track route to patient access for innovative medical technologies…